Addus HomeCare (ADUS)
(Delayed Data from NSDQ)
$94.54 USD
+2.84 (3.10%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $94.49 -0.05 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ADUS 94.54 +2.84(3.10%)
Will ADUS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ADUS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADUS
ADUS vs. USPH: Which Stock Is the Better Value Option?
Elevance Health (ELV), CD&R to Unveil Primary Care Offering
ADUS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Medical Stocks Lagging HCA Healthcare (HCA) This Year?
ADUS vs. USPH: Which Stock Should Value Investors Buy Now?
Acadia (ACHC) Buys CTCs to Boost Care Access in North Carolina
Other News for ADUS
Roblox upgraded, Qualcomm initiated: Wall Street's top analyst calls
Cracking The Code: Understanding Analyst Reviews For Addus HomeCare
Roblox upgraded, Qualcomm initiated: Wall Street's top analyst calls
Barclays downgrades Addus to Underweight on 'materially negative' regulation
Addus HomeCare Comments on Final Department of Health and Human Services Rule